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• To prepare ultrathin polyelectrolyte nanoreservoir  (UPN, Capsules) using 
LBL technique with subsequent core removal at low pH (1.1) and 
subsequently surface modification by using pluronic (PF-68). 
• To characterize the system in terms of encapsulation efficiency, surface 
morphology, LBL growth, in-vitro release profile, integrity of protein.
• To assess biocompatibility of the surface modified nanoreservoir.
INTRODUCTION
Most of the colloidal polymeric systems based on synthetic and natural 
polyelectrolyte has been investigated by layer-by-layer self assembly technique 
for microencapsulation and controlled release of macromolecules using different 
templates with size ranging from nanometer to tens of microns, such as organic 
and colloidal particles, protein aggregates, biological cells and drug nano or 
microcrystals. System has been prepared by the sequential deposition of the 
oppositely charged polyelectrolyte using the phenomenon of electrostatic 
interaction between each other. Most of the colloidal templates can be 
decomposed at conditions where polymeric matrix is stable, which leads to the 
formation of hollow polyelectrolyte capsules with defined size, shape and shell 
thickness. Encapsulation of macromolecules, proteins, and other biotherapeutics 
into developed systems is of great interest for pharmaceutics and biotechnology 
due to its capability to use such systems as micro and nanocontainers for 
controlled drug delivery.
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The fabrication of nanoreservoirs using combination of synthetic and natural 
polyelectrolyte seems to be promising carrier for therapeutic proteins without 
affecting its integrity. The surface modification of nanocapsules has successfully 
demonstrated biocompatibility and also reduced adhesion/phagocytosis to 
biological cells. Studies are still under way to obtain suitable combination by using 
combination of natural polyelectrolyte. 
A B
A: SEM of porous CaCO3 MP
B: SEM of fabricated capsules    
    Scale bar 1 mμ  
IN-VITRO RELEASE  PROFILE
•  Inorganic decomposable core (charge substrate) has been selected for LBL 
assembly of polyelectrolyte using electrostatic interaction due to its 
great importance in geo-, bio-, and material sciences, as well as due to its 
wide industrial, technological and drug delivery applications.
•  Shape, surface morphology and narrow size distribution ranging from 4-6 µm of 
the CaCO3  microparticles and fabricated capsules were presented by the 
SEM micrographs. The nanoreservoir are promising carrier for proteins since 
structural integrity of protein was not significantly affected by the 
entrapment procedure or any harsh conditions or the type of polymers 
used in the study. 
•  Zeta potential study and CLSM reveals layer-by-layer growth of the systems.
•  Both the systems exhibited biphasic release profile with initial burst followed 
by controlled release.
•  Further, surface modification renders the capsule more biocompatible 
compared to plane capsules. It would help combat undesirable biological 
processes,  such as phagocytosis of the colloidal carrier. 
CHARACTERIZATION
A and B: Entrapped and free 
protein for F-2 
[ (PAH/SA)5]; 
C and D: Entrapped and free 
protein for F-1 
[ (PAH/PSS)5]; 
E: Pure protein solution. 
F-1= (PAH/PSS)5–PAH; 
F-2= (PAH/PSS)5; 
F-3= (PAH/PSS)5–PAH-
PF68
F-4= (PAH/SA)5- PAH; 
F-5= (PAH/SA)5; 
CTL= J 774 
macrophages. 
A=10 µg/ml; B= 100 
µg/ml.
Fluorescence 
Microscopy
        CLSM
          F-1: (PAH/PSS)5;       F-II: (PAH/SA)5
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      Yellow arrows indicate phagocytosis of capsules where as orange indicates 
for cell adhesion. 
Gray  and red line indicating Transition of PF-
68 and Surface modified capsules respectively.
A, B & C: IR spectra of 
capsules, PF-68, surface 
modified capsules respectively. 
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Drug Re lease  Profile  in PBS (pH=7 .4 )
0
10
20
30
40
50
60
0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48
Ti m e (h rs )
%
 
Cu
m
u
la
ti
v
e
 
D
ru
g 
R
e
le
a
s
e
F-I F-II
PAH: Poly(allylamine) hydrochloride;
PSS: Polystyrene sulfonate sodium;
SA: Sodium alginate
SEM OF POROUS CaCO3 MP AND FABRICATED 
CAPSULES
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